J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.
Míriam Mañosa,M Calafat,R de Francisco,C. Garcia,María José Casanova,P. Huelin,Miguel Angel Marazuela Calvo,Joan Tosca,Luis Fernández-Salazar,C Arajol,Yamile Zabana,Guillermo Bastida,Joaquín Hinojosa,Lucía Márquez,M Barreiro-de-Acosta,Xavier Calvet,David Monfort,María Gómez-García,Esther Rodríguez,José María Huguet,M Rojas-Feria,Daniel Hervías,R. Atienza,David Busquets,Eva Zapata,Carmen Duenas,Mara Charro,Francesc Martínez-Cerezo,Rocío Plaza,J M Vázquez,Javier P. Gisbert,Fiorella Cañete,Eduard Cabré,E. Domènech,Geteccu +34 more
TL;DR: Onset during old age has been reported in upto 10% of total cases of inflammatory bowel disease (IBD) in people aged 60 and over.
Journal ArticleDOI
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.
Antonio López-Sanromán,Isabel Vera-Mendoza,E. Domènech,Carlos Taxonera,Vicente Vega Ruiz,Ignacio Marín-Jiménez,Jordi Guardiola,Luisa de Castro,Maria Esteve,Eva Iglesias,D Ceballos,Pilar Martínez-Montiel,Javier P. Gisbert,Miguel Minguez,Ana Echarri,Xavier Calvet,Jesús Barrio,Joaquín Hinojosa,María Dolores Martín-Arranz,Lucía Márquez-Mosquera,Fernando Bermejo,Jordi Rimola,Vicente Pons,Vicente Pons,Pilar Nos,Pilar Nos +25 more
TL;DR: ADA has not demonstrated a better efficacy than AZA [both associated with metronidazole] for prophylaxis of POR-CD in an unselected population, although tolerance to ADA is significantly better.
Journal ArticleDOI
Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: are antibiotics enough?
Fernando Bermejo,Elena Garrido,María Chaparro,Jordi Gordillo,Míriam Mañosa,Alicia Algaba,Antonio López-Sanromán,Javier P. Gisbert,Esther Garcia-Planella,Iván Guerra,Eugeni Domènech +10 more
TL;DR: Management of spontaneous AA in CD with antibiotics alone seems to be a good option for small abscesses, especially those without associated fistula and appearing in immunomodulator‐naïve patients.
Journal ArticleDOI
Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.
Silvio Danese,Matthieu Allez,Ad A. van Bodegraven,Iris Dotan,Iris Dotan,Javier P. Gisbert,Ailsa Hart,Peter L. Lakatos,Peter L. Lakatos,Fernando Magro,Laurent Peyrin-Biroulet,Stefan Schreiber,Dino Tarabar,Stephan R. Vavricka,Jonas Halfvarson,Severine Vermeire +15 more
TL;DR: An extensive literature review and consensus meeting to identify unmet needs in ulcerative colitis and ways to overcome them found a number of areas of unmet need, which is an important first step in tackling them in the future.
Journal ArticleDOI
Re-treatment after Helicobacter pylori eradication failure.
Javier P. Gisbert,Boixeda D,Fernando Bermejo,M Nieves Rincón,M Jesús Higes,M Angeles Arpa,I. García Arata,C. Martin De Argila,A García Plaza +8 more
TL;DR: BTT re-treatment in O + A failure achieves a relatively low eradication rate, probably lower than BTT for the first time, suggesting that other regimens should be tried.